4Tartarone A, Lerose R. Stevens-johnson syndrome and toxic eqidermal necrolysis: what do we know ? Ther Drug monit, 2010, 32 (6) :669-672.
5Hung SI, Chung WH, Liou LB, et al. HLA-B*5801allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proe Nat Acad Sei USA, 2005, 102 (11) :4134-4139.
6Endorf FW, Cancio LC, Gibran NS. Toxic epidermal necrolysis clinical guidelines. J Burn Care Res, 2008 (5) :706-712.
7Engelhardt SL, Schurr MJ, Helgerson RB. Toxic epidermal necrolysis: an analysis of referral patterns and steroid usage. J Burn Care Rehabil, 1997, 18 (6):520-524.
